Gottheimer Urges Speedy FDA Action on Experimental Gilead COVID-19 Treatment, Urges Gilead to Continue Emergency Access to Patients with Severe Symptoms

Mar 23, 2020

Gilead’s current halting of individual emergency access to COVID-19 treatment is placing lives at risk, like Fifth District native 25-year-old Jack Allard

On Monday, March, 23, 2020, U.S. Congressman Josh Gottheimer (NJ-5) released the following statement:

“Right now, Gilead Sciences has halted emergency individual ‘compassionate use’ access to its experimental COVID-19 drug remdesivir, citing overwhelming demand, as the company works to expand access programs. While compassionate use requests may still be made for pregnant women and children under 18 years of age with confirmed COVID-19 and severe manifestations of disease, this is leaving hundreds of other patients suffering from extreme symptoms of COVID-19 without treatment that could save their lives — including some patients in North Jersey, like 25-year-old Ridgewood native Jack Allard who is currently suffering from extreme COVID-19 complications.  

I’m calling on the U.S. Food and Drug Administration (FDA) to act on Gilead Sciences’ remdesivir COVID-19 investigational treatment application as swiftly as possible, and for Gilead to continue its individual emergency compassionate use access program, with physician approval, as they work diligently to develop expanded access programs. Now is the time for our government and life sciences companies to redouble their efforts and commitment to effectively treating patients, developing the cures we need, and providing access to those who need it most. Thousands of American lives depend on it. We cannot delay.”


Recent Posts

Dec 4, 2023

RELEASE: Gottheimer Calls On Rutgers University to Protect Students and Remove Antisemitic, Anti-Israel Speakers From December 7 Event

NORTH JERSEY — Today, December 4, 2023, U.S. Congressman Josh Gottheimer (NJ-5) wrote to Rutgers University President Jonathan Holloway, calling on him to take action in response to the University’s inclusion of antisemitic, anti-Israel, and hate-filled upcoming guest speakers Marc Lamont Hill and Nick Estes at a Rutgers-sponsored event on December 7 entitled “Race, Liberation, and […]

Dec 4, 2023

RELEASE: Gottheimer, Lawler Stand with NYC Restaurant Owner Against NY’s $15/Day Congestion Tax

Above: Gottheimer with Rep. Lawler and Julio Pena, co-owner of NYC restaurant Il Posto Accanto. NEW YORK, NY — Today, December 4, 2023, U.S. Congressmen Josh Gottheimer (NJ-5) and Mike Lawler (NY-17) joined Julio Pena, owner of restaurant Il Posto Accanto, to highlight the terrible impact New York’s proposed $15-a-day Congestion Tax will have on small […]

Nov 30, 2023

RELEASE: Gottheimer Statement on New York’s Congestion Tax

NORTH JERSEY — Today, November 29, 2023, U.S. Congressman Josh Gottheimer (NJ-5) released the following statement: “As advertised, New York is officially sticking it to Jersey families with their commuter-crushing Congestion Tax. On top of the existing tolls, it’ll be 15 bucks every day to go into the city with no discounts at the GW Bridge […]